SCHEMBL24865728

SCHEMBL24865728

Cn1c(=O)oc2cc(Nc3ccc4c(c3)n(C)c(=O)n4C)ccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.54
ALDH1A1 P00352 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
TP53 P04637 2/20 0.50
HSD17B10 Q99714 1/20 0.50
PKM P14618 5/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
GFER P55789 1/20 0.48
HTT P42858 2/20 0.46
MAPT P10636 1/20 0.46
GABRG2 P18507 1/20 0.46
GABRB3 P28472 1/20 0.46
GABRA5 P31644 1/20 0.46
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.46
POLB P06746 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
HPGD P15428 1/20 0.45
TRIM24 O15164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24865089 0.77 GABRG2 (0.49) KDM4EALDH1A1TP53PKMMEN1
SCHEMBL30336484 0.77 GABRG2 (0.49) KDM4EALDH1A1TP53PKMMEN1
SCHEMBL24865481 0.76 TRIM24 (0.61) ALDH1A1SMN1; SMN2TP53HSD17B10PKM
SCHEMBL30336455 0.75 KDM4E (0.47) KDM4EALDH1A1TP53PKMMEN1
SCHEMBL31123316 0.73 GABRG2 (0.46) KDM4EALDH1A1SMN1; SMN2TP53PKM
SCHEMBL24865206 0.73 SMN1; SMN2 (0.53) KDM4EALDH1A1SMN1; SMN2TP53HSD17B10
SCHEMBL24865065 0.73 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2TP53HSD17B10PKM
SCHEMBL30336923 0.73 SMN1; SMN2 (0.53) KDM4EALDH1A1SMN1; SMN2TP53HSD17B10
SCHEMBL3045237 0.73 ALDH1A1 (0.53) KDM4EALDH1A1PKMMEN1KMT2A
SCHEMBL29878389 0.73 ALDH1A1 (0.53) KDM4EALDH1A1PKMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-03 US disclosed
CN-117999259-A Iron death modulators, their preparation and use 维泰瑞隆有限公司 2024-05-07 CN disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 WO disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 KDM4E 3854/4885ALDH1A1 1306/4885SMN1; SMN2 1657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.